On June 23, 2025, the House Appropriations Committee met to consider the Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. The measure was approved by the Committee with a vote of 35 to 27. The bill provides a total discretionary allocation of $25.523 billion, which is $1.163 billion (4.2%) below the FY25 enacted level. See Subcommittee Chairman Andy Harris’s (R-MD) press release on the bill here.

The FY26 bill includes language that would ban hemp-derived cannabinoid (CBD) products containing synthetic compounds and/or quantifiable amounts of THC or THCA—or other cannabinoids that have similar effects on humans or animals. This language is similar to the “Miller Amendment” that was included in a 2025 House draft of the Farm Bill that failed to pass last session championed by Congresswoman Mary Miller (R-IL).

The bill report includes language urging the U.S. Food and Drug Administration (FDA) to expedite the Premarket Tobacco Applications process that states, “The Committee is concerned that many timely filed tobacco products still await review by FDA, and this delay in the review of filed applications is confusing consumers, distributors, and manufacturers. The Committee urges FDA to publish and regularly update guidance to communicate to manufacturers, distributors, and retailers an enforcement discretion policy for products with timely-filed and pending Premarket Tobacco Applications (PMTAs) and to prioritize any enforcement actions against products without pending PMTAs or that did not file timely applications.”